Introduction
Research on medicinal plants has shown that they are an important source of effective anti-cancer agents. More than half of the drugs used in clinical trials for anti-cancer activity are derived from natural sources 1 .
Kalanchoe is a genus of the Family Crassulaceae. Various species of Kalanchoe are used medicinally in Southeast Asia, speci ically Indo-China and Philippines. Plants of this genus are mentioned in folklore and are used as traditional medicines for treating fever, abscesses, bruises, contused wounds, coughs, skin diseases, infections, hypertension, rheumatism and in lammation [2] [3] and, in particular, tribes in the state of Kerala, India, use these plants for treating cancer symptoms. A variety of bufadienolide compounds have been isolated from various Kalanchoe species, which showed strong antitumour-promoting activity [4] [5] [6] . In one of the above cases, Kalanchoe hybrida was used. It is the hybrid of Kalanchoe daigremontiana and Kalanchoe tubiflora (KT) and is naturalized throughout the island of Taiwan. On the basis of the aforementioned studies, KT, one of the origin sources of the hybrid, was selected as a target given its biological activities. KT is used as a wound-healing agent in traditional South Brazilian medicine 7 . Few cardenolide and bufadienolide glycoside compounds were isolated from KT in Kuo group. Four of the isolated compounds have the capacity to arrest HL-60 cells in G2/M phase 8 . In our study, we used KT as an example to discuss agents that target mitotic cells.
Discussion
The authors have referenced some of their own studies in this review. The protocols of these studies have been approved by the relevant ethics committees related to the institution in which they were performed.
Anti-cancer activity
Schmidt et al. carried out a study to establish the biological properties of Brazilian plants used in wound healing 7 . By studying the different bioassays identi ied, Schmidt et al. found that KT did not show much promise as a potential treatment agent. In fact, KT showed a toxic effect in the MTT assay. This is consistent with the indings of our study 9 . Toxicity of KT was tested in different cell lines and different dosages. The cell viability for all cell lines was found to be 20% below the concentration level of 20μg/ml. Hence, there is suf icient evidence to suggest that KT extract effectively inhibits growth of different cancer cell lines.
The scratch assay in Schmidt's study showed that the n-hexanic extract of KT had no activity in the scratch assay at a concentration of 10μg/ml. The ethanoic extract showed a moderate 'wounding-healing' effect. However, in our study we found that KT extract completely blocked 'wound healing' at a concentration of 50μg/ml. Note that the scratch assay does not distinguish between migration and proliferation. However, in terms of anti-cancer activity, KT is a promising agent for anti-proliferation and/or anti-migration.
Anti-cancer mechanism
Mitosis is a highly coordinated process in which two copies of one chromosome are moved away from each other to the opposite poles of cells. Sister-chromatid segregation depends on a complex molecular scaffold of the mitotic spindle. Disruption of the mitotic spindle structure precludes proper alignment of chromosomes and activates the spindle assembly checkpoint and mitotic arrest, which
The anti-cancer activity of Kalanchoe tubifl ora YJ in turn provides time for cells to correct the attachment error between the microtubule and kinetochore. However, prolonged mitotic delay is often followed by cell death in mitosis. This is the strategy to kill cancer cells by perturbing mitotic spindle assembly. Microtubules play an important role in cell proliferation, traf icking and migration. Microtubules are a basic component of mitotic spindle. This is why agents that bind to microtubules are used in cancer therapy. Two clinical anti-cancer drugs, taxanes and vinca alkaloids, are natural products that affect microtubule dynamics and cause abnormal spindle formation [10] [11] [12] . However, microtubules are also present in interphase cells. Microtubule binding agents also perturb the microtubule network of interphase cells and cause neurotoxic effects 13 . The microtubule binding agents have side-effects unrelated to antimitotic effects. This warrants searching for more mitosis-selective drugs. The mitotic-selective approach targets proteins that function only in mitosis. Some of the drugs that target the six mitotic proteins are currently undergoing clinical trials. These mitotic proteins include two motor proteins (Eg5, CENP-E) and four kinases (Aurora A, Aurora B, Cdk1, Plk1) 14, 15 . Eg5 is a plus enddirected motor protein that drives centrosome separation in prophase 16 . Inhibition of Eg5 results in monopolar spindles causing mitotic arrest in a spindle-assembly-checkpointdependent manner 17, 18 . CENP-E is a kinetochore-associated protein that stabilizes the interactions between microtubules and kinetochore during mitosis 19 . It functions exclusively in mitosis. Inhibition of CENP-E leads to misaligned chromosomes in metaphase 20 . CDK1 is the main regulator for mitotic entry in mammalian cells 21 . Plk1, Aurora A and Aurora B regulate mitotic entry and ensure that chromosome segregation and cytokinesis events take place 22 . In our previous study, we found that KT extract also has the capacity to arrest cells in the G2/M phase. Drugs that bind to microtubules are able to arrest cells in G2/M. However, KT extract does not disturb the microtubule organization in interphase or spindle formation in mitosis. Instead, KT extract treatment resulted in mitotic defects. KT extract induces multipolar spindles ( Figure 1A ) and chromosome misalignment ( Figure 1B ). These defects Table 1 activate mitotic checkpoints and cause mitotic arrest 23 . The arrested mitotic cells are often followed by cell death in mitosis. Some of the mitotic defective cells could exit mitosis and end up in a tetraploid or aneuploid state. The fate of those mitotic checkpoint slippage cells could be apoptosis, senescence or necrosis 24 . Various compounds isolated from KT have been summarized in this critical review (Table 1) 8, 25 .
Conclusion
Finding ways to develop traditional herbal medicine is a matter of great urgency. Plants have chemical defence mechanisms that synthesize a wide variety of compounds that can be used to perform important biological functions and to defend against attack from predators. Many of these phytochemicals have bene icial effects, but some can have adverse or lethal effects on humans. However, no single chemical can effectively treat human diseases without side-effects. Isolation, identi ication and bioactive tests of pure compounds are standard strategies utilized in studying natural products. In many cases, scientists are not sure what speci ic ingredient in a particular herb can treat diseases. Whole herbs contain many ingredients that likely work together to produce a bene icial effect. Herbalists tend to use extracts from different parts of plants, such as roots or leaves, but do not isolate particular phytochemicals. They often reject the notion of a single active ingredient, arguing that the different phytochemicals present in many herbs will interact to enhance the therapeutic effects of the herbs and dilute toxicity. However, the activities of compounds isolated from plants are not necessarily parallel to the phenotypes observed in the traditional use of these plants.
A major aspect of traditional Chinese medicine focuses on restoring the homeostasis of the body to maintain health rather than treating a particular disease or medical condition. If used correctly, herbs can cure a variety of conditions, and in some cases, may have fewer sideeffects than some of the conventional medications. Here we would like to draw an open question. Shall we keep doing separation? In understanding the role of medicinal herbs in human physiology, one might end up with putting all the isolated components together in order to reveal how therapy works. Hence, we still have a long way to go in determining the most effective modalities of treatment that uses medicinal herbs. More scienti ic data and evidence-based research are needed to determine the effectiveness of medicinal herbs.
